Chain for claim_01da27ccf1c74676
8 nodes. Root first; inputs below.
depth 0 · claim · via classify
claim_01da27ccf1c74676
**Selected angle:** `source` ## One-sentence thesis semaglutide (1.8%) versus placebo (2.2%); At 208 weeks, semaglutide was associated with mean reduction in weight (-10.2%) versus placebo (-1.5%; P < 0.0001). **Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication. ## Why this is surpris…
sha256 e5f095468f71de3a…
depth 1 · source
source_f0450611a9f5435d
**Selected angle:** `source` ## One-sentence thesis semaglutide (1.8%) versus placebo (2.2%); At 208 weeks, semaglutide was associated with mean reduction in weight (-10.2%) versus placebo (-1.5%; P < 0.0001). **Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication. ## Why this is surpri…
sha256 5d186f4f300d4020…
depth 1 · source
source_08b572accba943f1
{"publication_id": "da7f5bc8-9764-4dfa-963a-fc3eda0b8042", "traces": [{"candidate_sources": [{"doi": "10.1038/s41591-024-03015-5", "study": "Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial", "url": null}, {"doi": "10.1038/s41591-024-02996-7", "study": "Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial", "…
sha256 b215212a17ceb9eb…
depth 1 · source
source_71d20e2d950d41b8
{"content_hash": null, "edges": [{"from": "da7f5bc8-9764-4dfa-963a-fc3eda0b8042", "to": "claim_1", "type": "contains_claim"}, {"from": "da7f5bc8-9764-4dfa-963a-fc3eda0b8042", "to": "claim_2", "type": "contains_claim"}, {"from": "da7f5bc8-9764-4dfa-963a-fc3eda0b8042", "to": "claim_3", "type": "contains_claim"}], "nodes": [{"id": "da7f5bc8-9764-4dfa-963a-fc3eda0b8042", "title": "Semaglutide once: se…
sha256 50a2789b9bdde484…
depth 1 · source
source_b845ece3a5754194
{"contradictions": ["_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._"], "limitations": ["This is an agent-assisted alpha memo, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty f…
sha256 69b5fff1c46f605f…
depth 1 · source
source_4c5b721099b240d1
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial,not…
sha256 5953955fc6d7de80…
depth 1 · source
source_add0f43c880f4d00
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "da7f5bc8-9764-4dfa-963a-fc3eda0b8042", "sources": [{"directness": "primary", "doi": "10.1038/s41591-024-03015-5", "risk_of_bias": "not appraised in public sidecar", "study": "Long-term kidney outcomes of semaglutide in obesity and cardio…
sha256 0a17eb1d3a443e43…
depth 1 · source
source_1b7f9ab4764a4fc9
{"decision": "accept", "gate_failures": [], "notes": ["accepted and queued for publish"], "review_recommendation": "accept"}
sha256 6892ae790ff081ca…